Selectis Health, Inc.
GBCS
$2.20
-$0.05-2.22%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | 1.32% | 1.58% | 30.35% |
| Total Other Revenue | 14.97% | 12.71% | 7.46% | -1.23% | -15.30% |
| Total Revenue | 12.99% | 10.73% | 7.35% | -1.18% | -14.78% |
| Cost of Revenue | 1.61% | -1.62% | -0.13% | -11.85% | -10.66% |
| Gross Profit | 73.28% | 81.32% | 44.27% | 81.61% | -31.51% |
| SG&A Expenses | -43.69% | -4.78% | -4.70% | -13.85% | 28.90% |
| Depreciation & Amortization | -15.81% | 4.53% | -6.68% | -3.44% | -3.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.94% | -2.36% | -1.55% | -11.98% | -0.29% |
| Operating Income | 96.75% | 51.45% | 51.75% | 64.66% | -108.94% |
| Income Before Tax | 84.13% | 28.96% | 137.81% | -125.71% | -65.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 84.13% | 28.96% | 137.81% | -125.71% | -65.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.13% | 28.96% | 137.81% | -125.71% | -65.73% |
| EBIT | 96.75% | 51.45% | 51.75% | 64.66% | -108.94% |
| EBITDA | 110.36% | 61.20% | 69.03% | 82.20% | -159.27% |
| EPS Basic | 84.23% | 29.16% | 137.16% | -125.83% | -65.50% |
| Normalized Basic EPS | 83.72% | 42.39% | 37.53% | 56.60% | -73.50% |
| EPS Diluted | 83.33% | 29.16% | 137.16% | -125.85% | -66.64% |
| Normalized Diluted EPS | 83.72% | 42.39% | 37.53% | 56.60% | -73.50% |
| Average Basic Shares Outstanding | 0.41% | 0.41% | 0.41% | 0.41% | 0.00% |
| Average Diluted Shares Outstanding | 0.41% | 0.41% | 0.41% | 0.41% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | 1.00% |